PND7 Cost-Effectiveness of Cladribine Tablets in the Treatment of Relapsing-Remitting Multiple Sclerosis with High Disease Activity in Kazakhstan

The requested reference [b1f7a6e4f230db1e02e5fd1353224ca66c367e1d] no longer exists in our database. It has been replaced by the current reference: [114569aa129338f3fb4267b373f44cac317a0414]

Authors
Category Primary study
JournalValue in Health Regional Issues
Year 2020
This article has no abstract
Epistemonikos ID: 1fd38c6396cd6ce9a5df91530390bf1daeb9bfa4
First added on: Feb 12, 2025